Cirkonio kalvė - Company finances
|
EUR
|
2021
From: 2021-03-17
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 54,549 | 111,075 | 112,864 | 146,153 | 106,978 |
| Profit before tax | 10,377 | 9,753 | 1,171 | 35,187 | 12,981 |
| Net profit | 10,377 | 9,165 | 1,074 | 33,384 | 11,909 |
| Equity | 10,377 | 19,542 | 21,116 | 34,400 | 18,209 |
| Liabilities | 71 | 2,517 | 23,435 | 9,528 | 4,152 |
| Non-current assets | 556 | 2,915 | 28,840 | 22,806 | 12,677 |
| Current assets | 9,892 | 19,144 | 15,711 | 21,116 | 9,679 |
| Total assets | 10,448 | 22,059 | 44,551 | 43,922 | 22,356 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 2,241 | 1,700 | 2,433 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +103.6% | +1.6% | +29.5% | -26.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 99.3% | 41.5% | 2.4% | 76.0% | 53.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 46.9% | 5.1% | 97.0% | 65.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 19.0% | 8.3% | 1.0% | 22.8% | 11.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 19.0% | 8.8% | 1.0% | 24.1% | 12.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 1.1 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Cirkonio kalvė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-06-03 | 2025-06-30 | 72.45 |
| 2025-04-01 | 2025-04-30 | 72.45 |
| 2025-02-01 | 2025-02-28 | 7.95 |
| 2024-09-03 | 2024-09-30 | 64.50 |
| 2024-06-03 | 2024-06-30 | 64.50 |
| 2024-04-03 | 2024-04-30 | 3.00 |
| 2023-10-03 | 2023-10-31 | 8.43 |
| 2023-09-01 | 2023-09-30 | 117.26 |
| 2023-08-01 | 2023-08-31 | 58.63 |
| 2023-07-19 | 2023-07-20 | 215.73 |
| 2023-07-03 | 2023-07-17 | 50.20 |
| 2023-06-01 | 2023-07-02 | 111.57 |
| 2023-05-04 | 2023-05-31 | 52.94 |
| 2023-03-01 | 2023-03-31 | 135.68 |
| 2023-02-01 | 2023-02-28 | 77.05 |
| 2023-01-03 | 2023-01-31 | 18.42 |
| 2022-06-01 | 2022-07-31 | 50.95 |
| 2022-04-01 | 2022-04-30 | 6.14 |
| 2021-10-01 | 2021-10-31 | 44.81 |
Cirkonio kalvė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-19 | 2025-10-06 | 0.49 |
| 2025-04-17 | 2025-04-25 | 1.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Cirkonio kalve, MB (code 305716608) is a small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In the latest financial year, 2025, the company generated revenue of €107.0K and net profit of €11.9K, with a profit margin of 11.1%. Revenue declined by 26.8% year on year from €146.2K in 2024, after increasing from €112.9K in 2023. Profitability followed a similar pattern: net profit rose sharply from €1.1K in 2023 to €33.4K in 2024, then eased in 2025 while remaining positive. At year-end 2025, total assets stood at €22.4K, equity at €18.2K and liabilities at €4.2K. The balance sheet remained lightly leveraged, with a debt-to-equity ratio of 0.23 and an equity ratio of 81.5%. Reported efficiency indicators were strong, including ROE of 65.4%, ROA of 53.3% and asset turnover of 4.79x. Over the three-year period, the company showed a clear peak in 2024 followed by a smaller but still profitable 2025.